FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients

AMGN: Amgen
2018-12-14 16:00:00
FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia